Skip to content
UM-SCC-128
Tissue
Head and neck, oral cavity
Disease
Head and neck squamous cell carcinoma (HNSCC)
Metastatic site
Primary tumor site (head and neck)

Documents

UM-SCC-128

Cell line · Product number 305726

UM-SCC-128 is a human HNSCC cell line from the University of Michigan UM-SCC panel, growing as an adherent monolayer with epithelial-like morphology. It i...

€777.00excl. tax and shipping

Customization / Recommendations

Made to order
1

01General information

Description

UM-SCC-128 is a human HNSCC cell line from the University of Michigan UM-SCC panel, growing as an adherent monolayer with epithelial-like morphology. It is part of the higher-numbered UM-SCC series and provides a model for comparative preclinical HNSCC studies.

Applicable in HNSCC research, drug sensitivity and resistance studies, radiation response, and UM-SCC multi-line panel comparative experiments. Suitable for pharmacological screening and xenograft models.

Tissue
Head and neck, oral cavity
Disease
Head and neck squamous cell carcinoma (HNSCC)
Metastatic site
Primary tumor site (head and neck)
Applications
HNSCC research; drug sensitivity and resistance; radiation response; UM-SCC panel studies; xenograft models

02Classification

Organism
Human
Sex
Unspecified
Growth properties
Adherent
GMO status
Non-GMO
GMO status details
No genetic modification; wildtype HNSCC cell line
Biosafety level
1

03Characteristics

Morphology
Epithelial-like
Cell type
Epithelial cells
Doubling time
approx. 24 to 48 hours

04Identifiers

Citation
UM-SCC-128 (Cytion catalog number 305726)
NCBI TaxID
9606
Cellosaurus
Not assigned

05Handling and culture

Culture medium
DMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 3.7 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
Incubation atmosphere

37°C, 5% CO2, humidified atmosphere.

Supplements
Supplement the medium with 10% FBS and 1% non-essential amino acids (NEAA)
Dissociation reagent
Accutase
Subculturing
Remove medium, wash with PBS without calcium and magnesium, cover with Accutase, incubate 8–10 min at RT, resuspend in medium, centrifuge 300×g 3 min, discard supernatant, reseed in fresh medium.
Split ratio
1 to 5
Seeding density
1 to 3 × 104 cells/cm2
Fluid renewal
Every 2 to 3 days
Thawing and culturing
  1. Confirm that the vial remains deeply frozen upon delivery, as cells are shipped on dry ice to maintain optimal temperatures during transit.

  2. Upon receipt, either store the cryovial immediately at temperatures below -150°C to ensure the preservation of cellular integrity, or proceed to step 3 if immediate culturing is required.

  3. For immediate culturing, swiftly thaw the vial by immersing it in a 37°C water bath with clean water and an antimicrobial agent, agitating gently for 40-60 seconds until a small ice clump remains.

  4. Perform all subsequent steps under sterile conditions in a flow hood, disinfecting the cryovial with 70% ethanol before opening.

  5. Carefully open the disinfected vial and transfer the cell suspension into a 15 ml centrifuge tube containing 8 ml of room-temperature culture medium, mixing gently.

  6. Centrifuge the mixture at 200 x g for 5 minutes, carefully discard the supernatant containing freezing medium.

  7. Follow the procedure described under Post-Thaw Recovery

06Quality control and cryopreservation

Freeze medium
As a cryopreservation medium, we use complete growth medium + 10% DMSO for adequate post-thaw viability.
Storage conditions

For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen.

Shipping conditions

Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage.

07Donor

Donor age
Age unspecified
Ethnicity
Ethnicity unspecified